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Case Description
67-year-old nursing home resident with PMH of MI, diabetes, hypertension, seizures, and left AKA
presents to the ER due to altered mental status and hypoxia. Nursing home staff reported patient had
fallen from bed, and during evaluation, he was found to be altered and hypoxic to 80% on room air.
He is normally wheelchair-bound but participates in nursing home activities and well-oriented at
baseline. Upon arrival, patient was encephalopathic with GCS 10 and no focal deficits. His vital
signs were T 36C, HR 110, BP 119/102, RR 22, and SpO2 96% on 15L nonrebreather. He had dry
mucous membranes, clear breath sounds with good respiratory effort, soft abdomen, and no other
skin or joint findings. He did not tolerate any oxygen weaning, but since he was protecting his
airway, he was transitioned to Salter nasal canula 15L. Given the ongoing pandemic and hypoxia of
unknown etiology, COVID-19 nasopharyngeal PCR swab was performed. ABG revealed pH 7.43,
pCO2 31.5, and paO2 at 87.8. Although a normal paO2, this was drawn while patient was on a
nonrebreather, and thus it was more telling of his hypoxemia.
A 1-view AP chest x-ray in the resus room demonstrated hazy opacities in right upper lobe,
perihilar, and infrahilar regions, reported as nonspecific findings for atypical or multifocal
pneumonia (Figure 1). ECG revealed sinus tachycardia with new T-wave inversions in V2-3 and
slightly prolonged QTc 512. Sepsis workup was initiated with blood cultures, urinalysis, and
empiric treatment with vancomycin, ceftriaxone, flagyl, and 1L LR bolus for pneumonia. A dose of
methylprednisolone 40mg was additionally given for suspected COVID-19 infection. CT head
showed 2 small areas of acute to subacute infarcts in right inferior parietal and inferior cerebellum
(Figures 2-3). Neurology team favored these as incidental findings that did not explain his
encephalopathy.
As listed in Table 1, abnormalities in the metabolic panel primarily were the hemolyzed K 8.4 and
Cr 1.72 (baseline 0.3-0.4). Despite the hemolyzed specimen, due to his prolonged QTc and the
magnitude of the potassium elevation. His whole blood K later returned at 3.1. His CRP was 14.0,
ESR 20, LDH 2005, mild total bilirubinemia 3.0 without significant transaminitis, and haptoglobin
<30. Keppra level was supratherapeutic at 57.6 mg/L. He also had a leukocytosis at 13.9 with
lymphocytopenia at 0.14, hemoglobin 13.2, and platelets 52. More importantly, he had an elevated
coagulation profile with INR at 2.68, PT 27.8s, and PTT 44s. High-sensitivity troponins and BNP
later returned significantly elevated at 1649 and 808, respectively. As our patient was not on any
anticoagulants and presenting with a perceivably pro-thrombotic state with suspected hemolysis,
there was concern for TTP vs. DIC. A bedside ECHO showed normal EF left ventricular function,
but right ventricle appeared slightly enlarged with mild septal bowing. No pericardial effusion was
visualized. His inferior vena cava was collapsed, so he was given an additional bolus. CTPE could
not be pursued as patient had documented severe iodine allergy. DIC panel subsequently revealed ddimer >20 and low fibrinogen <60. During this workup, patient’s PCR swab resulted as positive for
COVID-19. He was given 2U cryoprecipitate while hematology was consulted for possible TTP.
Despite his encephalopathy, AKI, thrombocytopenia, and evidence of MAHA from lab findings,
hematology favored DIC due to his overall pro-thrombotic state, prolonged coagulation parameters,
and a clear precipitant of sepsis, likely from COVID-19. Patient was admitted to the MICU for
further management.

Discussion
• The cytokine storm precipitated by SARS-CoV2 virus leads to activation of platelets and
the coagulation cascade.
• Elevated D-dimer and PT have been significantly associated with poor prognosis in a
retrospective study by Tang et al.
• Treatment of the underlying disease as always been the hallmark of DIC management, but
this is difficult to do with the lack of evidence-based therapeutics available for the
treatment of COVID-19

Conclusion
• Testing a coagulation profile upon presentation for suspected COVID-19 patients can help
identify a dysfunctional hemostatic system as a sign of a hyperinflammatory response.
• Early detection of DIC is paramount in order to promptly initiate appropriate therapies as
well as to determine a valuable prognostic indicator.
• While our frontline physicians are becoming more familiarized with clinical
characteristics related to SARS-CoV2, the abnormalities in coagulation, especially leading
to DIC, in critically ill patients still warrant attention and further in-depth research
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Differential Diagnosis
Altered mental status

Hypoxic respiratory failure

Post-ictal state

Multifocal bacterial pneumonia

Intracranial hemorrhage

Aspiration pneumonia

Ischemic stroke

Pulmonary embolism

Sepsis-induced encephalopathy

Pneumothorax/hemothorax

Hypoxia-induced encephalopathy

ARDS

Severe electrolyte derangements
(hyponatremia, hypercalcemia

COVID-19 pneumonia
Figure 1. Chest x-ray image

Table
Labs

Results

Reference Ranges

Sodium (Na)

129

135-145 mmol/L

Potassium (K)

8.4

3.5-5.0 mmol/L (hemolyzed)

Whole blood potassium

3.1

Chloride (Cl)

96

98-111 mmol/L

BUN

58

10-25 mg/dL

Creatinine (Cr)

1.72 (baseline 0.3-0.4)

<1.2 mg/dL

Calcium

8.0

8.6-10.4 mg/dL

ALT

17

<52 IU/L

AST

94 (hemolyzed)

<35 IU/L

Albumin

3.4

3.2-4.6 g/dL

Total bilirubin (Tbili)

3.0

<1.2 mg/dL

Direct bilirubin

0.5

0-0.3 mg/dL

Figure 2. Computed Tomographic image
of right inferior parietal lobe infarct
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High-sensitivity (hs) troponin

1649

<18 ng/L
4.

Brain natriuretic peptide (BNP)

808

<50 pg/mL

Creatine kinase (CPK)

316

<250 IU/L

C-reactive protein (CRP)

14.0

<0.5 mg/dL

Erythrocyte sedimentation rate

20

<20 mm/Hr

Lactate dehydrogenase (LDH)
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(ESR)
2005

<250 IU/L

Ferritin

204

24-336 ng/mL

Haptoglobin

<30.0

30-200 mg/dL

WBC

13.9

3.8-10.6 K/uL

Absolute lymphocyte count (ALC)

0.14

1.10-4.0 K/uL

Absolute neutrophil count (ANC)

13.62

1.80-7.70 K/uL

Hemoglobin (Hgb)

13.2

13.5-17.0 g/dL

Hematocrit

39.9

41-53 %

Platelets (plts)

52

150-450 K/uL

INR

2.68
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Prothrombin time (PT)

27.8

12.1-14.5 sec

Partial thromboplastin time (PTT)

44

22-36 sec

D-dimer

>20.0

<0.67 (age-adjusted) ug/mL

Fibrinogen

<60

200-450 mg/dL

Levetiracetam (Keppra)

57.6

12.0-46.0 mg/L

Figure 3. Computed Tomographic image
of right inferior cerebellar infarct
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Case Follow-up
• Infectious disease determined patient was not a candidate for remdisivir or
tocilizumab
• Patient clinically deteriorated with uptrending lactic acid, troponins, worsening
renal failure, persistent DIC, and eventually into septic shock
• Nursing home Director of Nursing confirmed patient’s previous desires to be
DNAR
• Patient developed wide-complex tachycardia and passed away 2 days later

